Advanced search
Publication Cover
Future Cardiology Volume 4, 2008 - Issue 2
Submit an article Journal homepage
75
Views
0
CrossRef citations to date
0
Altmetric
Perspective

A Vaccine Against Atherosclerosis: Myth Or reality?

Gijs HM van Puijveldea Leiden University LACDR Division of BiopharmaceuticsEinsteinweg 552300 RALeidenThe Netherlands. Tel: +31 715 276 051; Fax: +31 715 276 032; [email protected]
,
Thomas van Esb Leiden University Division of BiopharmaceuticsLeidenThe Netherlands. Tel: +31 715 276 038; Fax: +31 715 276 032; [email protected]
,
Kim LL Habetsc Leiden University Division of BiopharmaceuticsLeidenThe Netherlands. Tel: +31 715 276 051; Fax: +31 715 276 032; [email protected]
,
Arnaud D Hauerd Leiden University Division of BiopharmaceuticsLeidenThe Netherlands. Tel: +31 715 276 051; Fax: +31 715 276 032; [email protected]
,
Theo JC van Berkele Leiden University Division of BiopharmaceuticsLeidenThe Netherlands. Tel: +31 715 276 216; Fax: +31 715 276 032; [email protected]
&
Johan Kuiperf Leiden University Division of BiopharmaceuticsLeidenThe Netherlands. Tel: +31 715 274 378; Fax: +31 715 276 032; [email protected]
Pages 125-133 | Published online: 28 Feb 2008

Bibliography

  • Robertson AK , HanssonGK: T cells in atherogenesis: for better or for worse?Arterioscler. Thromb. Vasc. Biol., 26, 2421–2432 (2006).
  • Hansson GK , LibbyP: The immune response in atherosclerosis: a double-edged sword.Nat. Rev. Immunol., 6, 508–519 (2006).
  • Tedgui A , MallatZ: Cytokines in atherosclerosis: pathogenic and regulatory pathways.Physiol. Rev., 86, 515–581 (2006).
  • Mallat Z , Ait-OufellaH, TedguiA: Regulatory T cell responses: potential role in the control of atherosclerosis.Curr. Opin. Lipidol., 16, 518–524 (2005).
  • Uyttenhove C , ArendseB, StroobantV, BrombacherF, Van Snick J: Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur. J. Immunol., 34, 3572–3581 (2004).
  • Delavallee L et al. , Le Buanec H, Bessis N : Early and long-lasting protection from arthritis in TNFα transgenic mice vaccinated against TNFα. Ann. Rheum. Dis. DOI: https://doi.org/10.1136/ard.2007.079137 (2007) (Epub ahead of print).
  • Rohn TA , JenningsGT, HernandezMet al.: Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis. Eur. J. Immunol., 36, 2857–2867 (2006).
  • Prasad A , ZhuJ, HalcoxJP, WaclawiwMA, EpsteinSE, QuyyumiAA: Predisposition to atherosclerosis by infections: role of endothelial dysfunction.Circulation, 106, 184–190 (2002).
  • Vliegen I , DuijvestijnA, GraulsG, HerngreenS, BruggemanC, StassenF: Cytomegalovirus infection aggravates atherogenesis in ApoE knockout mice by both local and systemic immune activation.Microbes Infect., 6, 17–24 (2004).
  • Hauer AD et al. , de Vos P, Peterse N : Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice. Cardiovasc. Res., 69, 280–288 (2006).
  • Hansson GK , ZhouX, TornquistE, PaulssonG: The role of adaptive immunity in atherosclerosis.Ann. NY Acad. Sci., 902, 53–62; discussion 62–54 (2000).
  • Hansson GK : Immune mechanisms in atherosclerosis.Arterioscler. Thromb. Vasc. Biol., 21, 1876–1890 (2001).
  • Wildbaum G , YoussefS, KarinN: A targeted DNA vaccine augments the natural immune response to self TNF-α and suppresses ongoing adjuvant arthritis.J. Immunol., 165, 5860–5866 (2000).
  • Youssef S , WildbaumG, KarinN: Prevention of experimental autoimmune encephalomyelitis by MIP-1α and MCP-1 naked DNA vaccines.J. Autoimmun., 13, 21–29 (1999).
  • Uyttenhove C , SommereynsC, TheateI, MichielsT, Van Snick J: Anti-IL-17A autovaccination prevents clinical and histological manifestations of experimental autoimmune encephalomyelitis. Ann. NY Acad. Sci., 1110, 330–336 (2007).
  • Hauer AD , UyttenhoveCet al., de Vos P : Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis. Circulation, 112, 1054–1062 (2005).
  • Gaofu Q , JunL, XinYet al.: Vaccinating rabbits with a cholesteryl ester transfer protein (CETP) B-cell epitope carried by heat shock protein-65 (HSP65) for inducing anti-CETP antibodies and reducing aortic lesions in vivo. J. Cardiovasc. Pharmacol., 45, 591–598 (2005).
  • Rittershaus CW , MillerDP, ThomasLJet al.: Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 20, 2106–2112 (2000).
  • Singh M , SrivastavaI: Advances in vaccine adjuvants for infectious diseases.Curr. HIV Res., 1, 309–320 (2003).
  • Singh M , O‘HaganD: Advances in vaccine adjuvants.Nat. Biotechnol., 17, 1075–1081 (1999).
  • Kastelein JJ et al. , van Leuven SI, Burgess L : Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. N. Engl. J. Med., 356, 1620–1630 (2007).
  • Dzhambazov B , NandakumarKS, Kihlberg J, Fugger L, Holmdahl R, Vestberg M: Therapeutic vaccination of active arthritis with a glycosylated collagen type II peptide in complex with MHC class II molecules. J. Immunol., 176, 1525–1533 (2006).
  • Strid J , TanLA, StrobelS, LondeiM, CallardR: Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.PLoS ONE, 2, e387 (2007).
  • Petrushina I , GhochikyanAet al., Mktrichyan M : Alzheimer‘s disease peptide epitope vaccine reduces insoluble but not soluble/oligomeric Aβ species in amyloid precursor protein transgenic mice. J. Neurosci., 27, 12721–12731 (2007).
  • Majewska M , ZajacK, SrebroZet al.: Epicutaneous immunization with myelin basic protein protects from the experimental autoimmune encephalomyelitis. Pharmacol. Rep., 59, 74–79 (2007).
  • Fredrikson GN , HedbladB, BerglundGet al.: Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease. Stroke, 38, 1495–1500 (2007).
  • Xu Q , SchettG, SeitzCS, HuY, GuptaRS, WickG: Surface staining and cytotoxic activity of heat-shock protein 60 antibody in stressed aortic endothelial cells.Circ. Res., 75, 1078–1085 (1994).
  • Afek A , GeorgeJ, GilburdBet al.: Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis. J. Autoimmun., 14, 115–121 (2000).
  • George J , ShoenfeldY, AfekAet al.: Enhanced fatty streak formation in C57BL/6J mice by immunization with heat shock protein-65. Arterioscler. Thromb. Vasc. Biol., 19, 505–510 (1999).
  • Virella G , Lopes-VirellaMF: Humoral immunity and atherosclerosis.Nat. Med., 9, 243–244; author reply 244–245 (2003).
  • Lopes-Virella MF , VirellaG, OrchardTJet al.: Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus. Clin. Immunol., 90, 165–172 (1999).
  • Chyu KY , ZhaoX, ReyesOSet al.: Immunization using an Apo B-100 related epitope reduces atherosclerosis and plaque inflammation in hypercholesterolemic Apo E (-/-) mice. Biochem. Biophys. Res. Commun., 338, 1982–1989 (2005).
  • Fredrikson GN , SoderbergI, LindholmMet al.: Inhibition of atherosclerosis in ApoE-null mice by immunization with ApoB-100 peptide sequences. Arterioscler. Thromb. Vasc. Biol., 23, 879–884 (2003).
  • Binder CJ , HorkkoS, DewanAet al.: Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL. Nat. Med., 9, 736–743 (2003).
  • Caligiuri G , Khallou-LaschetJ, VandaeleMet al.: Phosphorylcholine-targeting immunization reduces atherosclerosis. J. Am. Coll. Cardiol., 50, 540–546 (2007).
  • Walczak A , SzymanskaB, SelmajK: Differential prevention of experimental autoimmune encephalomyelitis with antigen-specific DNA vaccination.Clin. Neurol. Neurosurg., 106, 241–245 (2004).
  • Shen Y , ChenJ, ZhangX, WuX, XuQ: Human TNF-α gene vaccination prevents collagen-induced arthritis in mice.Int. Immunopharmacol., 7, 1140–1149 (2007).
  • Hauer AD et al. , van Puijvelde GH, Peterse N : Vaccination against VEGFR2 attenuates initiation and progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 27, 2050–2057 (2007).
  • Bosello S , SantoliquidoA, ZoliAet al.: TNF-α blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis. Clin. Rheumatol. DOI: https://doi.org/10.1007/s10067-007-0803-y (2007) (Epub ahead of print).
  • Faria-Neto JR , ChyuKY, LiXet al.: Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis, 189, 83–90 (2006).
  • Schiopu A , BengtssonJ, SoderbergIet al.: Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. Circulation, 110, 2047–2052 (2004).
  • Zhu P , LiXY, WangHKet al.: Oral administration of type-II collagen peptide 250–270 suppresses specific cellular and humoral immune response in collagen-induced arthritis. Clin. Immunol., 122, 75–84 (2007).
  • Gonnella PA , KodaliD, WeinerHL: Induction of low dose oral tolerance in monocyte chemoattractant protein-1- and CCR2-deficient mice.J. Immunol., 170, 2316–2322 (2003).
  • Harats D , YacovN, GilburdB, Shoenfeld Y, George J: Oral tolerance with heat shock protein 65 attenuates Mycobacterium tuberculosis-induced and high-fat-diet-driven atherosclerotic lesions. J. Am. Coll. Cardiol., 40, 1333–1338 (2002).
  • Maron R , SukhovaG, FariaAMet al.: Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice. Circulation, 106, 1708–1715 (2002).
  • George J , YacovN, BreitbartEet al.: Suppression of early atherosclerosis in LDL-receptor deficient mice by oral tolerance with β 2-glycoprotein I. Cardiovasc. Res., 62, 603–609 (2004).
  • van Puijvelde GH , HauerADet al., de Vos P : Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis. Circulation, 114, 1968–1976 (2006).
  • van Puijvelde GH et al. , van Es T, van Wanrooij EJ : Induction of oral tolerance to HSP60 or an HSP60-peptide activates T cell regulation and reduces atherosclerosis. Arterioscler. Thromb. Vasc. Biol. DOI: https://doi.org/10.1161/ATVBAHA.107.151274 (2007) (Epub ahead of print).
  • Ait-Oufella H , SalomonBL, PotteauxSet al.: Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med., 12, 178–180 (2006).
  • Steffens S , BurgerF, PelliGet al.: Short-term treatment with anti-CD3 antibody reduces the development and progression of atherosclerosis in mice. Circulation, 114, 1977–1984 (2006).
  • Mallat Z , GojovaA, BrunVet al.: Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice. Circulation, 108, 1232–1237 (2003).
  • Yang K , LiD, LuoM, HuY: Generation of HSP60-specific regulatory T cell and effect on atherosclerosis.Cell. Immunol., 243, 90–95 (2006).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.